EVALUATION OF ASPIRIN USAGE SAFETY IN CORONARY BYPASS SURGERY

Recent guidelines it is permitted to continue aspirin before coronary bypass operation (CBG) (Class I, Level B). Nevertheless, absence of randomized multicenter studies makes it possible not to follow these in routine practice as the only. Practive of aspirin discontinuation before CBG is quite common due to anticipated risks of post-surgery complications.

Aim. To evaluate the safety of CBG with continued aspirin.

Material and methods. For the safety assessment of aspirin before CBG, we conducted prospective randomized study. Patients with stable coronary heart disease were included, who underwent CBG with continued aspirin (aspirin group), and another group included those who had aspirin discontinued (controls). Totally, 74 patients randomized. Treatment group included 37 patients, and 37 controls. Follow-up lasted for 5 minutes. As primary endpoint, the volume of operational blood loss was taken, during the next 24 hours post-surgery. As the second endpoint, the combination was taken as any cardiovascular adverse event: cardiac death, perioperational myocardial infarction, ischemic stroke.

Results. There was noted, the comparability of intraoperational blood loss in comparison groups (p=0,166). Summary blood loss in 24 hours of postoperational blood loss showed statistical significance between groups (mean difference 100 mL, 95% CI 0-110 mL, p=0,027). This amount of blood loss is clinically non-significant. In aspirin group, there were 2 cases of perioperational myocardial infarction, by cardiac enzymes elevation, not statistically significant.

Conclusion. Results of the study witness for the safety of CBG operations under continued aspirin as well as discontinued at least 5 days before surgery.

1. Devereaux PJ, Mrkobrada M, Sessler DI et al. Aspirin in patients undergoing noncardiac surgery. N Engl J Med. 2014 Apr 17; 370 (16):1494–503.

2. А. А. M. Chernyavskiy , A. S. Nesmachnyy , T. M. Ruzmatov , A. V. Boboshko , D. A. Nikolaev , V. A. Boboshko , V. U. Efendiev , T. N. Podsosnikova. Surgical on-pump beating-heart treatment of ischemic patients with low LF ejection fraction: immediate results. Patol. krovoobrash. kardiokhir.2015;19(1):51-58. Russian (Чернявский А. М., Несмачный А. С., Рузматов Т. М., Бобошко А. В., Николаев Д. А., Бобошко В. А., Эфендиев В. У., Подсосникова Т. Н. Хирургическое лечение ишемической болезни сердца у пациентов с низкой фракцией выброса левого желудочка на работающем сердце в условиях искусственного кровообращения: непосредственные результаты. Патология кровообращения и кардиохирургия. 2015;19(1):51-58). http://dx.doi.org/10.21688/1681-3472-2015-1-51-58

3. Kamran M, Ahmed A, Dar MI, Khan AB. Effect of aspirin on postoperative bleeding in coronary artery bypass grafting. Ann Thorac Cardiovasc Surg. 2008 Aug; 14 (4):224–9.

4. Kallis P, Tooze JA, Talbot S et al. Preoperative aspirin decreases platelet aggregation and increases postoperative blood loss: a prospective, randomised, placebo controlled, double-blind clinical trial in 100 patients with chronic stable angina. Eur J Cardiothorac Surg. 1994; 8 (8):404–9

5. Low-dose aspirin for secondary cardiovascular prevention – cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation review a meta-analysis / W. Burger, J. M. Chemnitius, G. D. Kneissl [et al.] // J. Intern. Med. – 2005. – Vol. 257. – P. 399–414.

6. Kamran M, Ahmed A, Dar MI, Khan AB. Effect of aspirin on postoperative bleeding in coronary artery bypass grafting. Ann Thorac Cardiovasc Surg. 2008 Aug; 14 (4):224–9.

7. Lewis HD Jr, Davis JW, Archibald DG, Steinke WE, Smitherman TC, Doherty JE 3rd, Schnaper HW, LeWinter MM, Linares E, Pouget JM, Sabharwal SC, Chesler E, DeMots H. Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. Results of a Veterans Administration Cooperative Study.N Engl J Med. 1983 Aug 18; 309(7):396-403

8. Antithrombotic Trialists’ Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high-risk patients. BMJ 2002; 324:71—86

9. WHO Model Lists of Essential Medicines. ADULTS -- 19th edition (April 2015) -- Rev. November 2015

10. Serebruany V.L., Malinin A.I., Eisert R.M., and Sane D.C. Risk of bleeding complications with antiplatelet agents: meta-analysis of 338,191 patients enrolled in 50 randomized controlled trials. Am J Hematol 2004; 75:40—47.

11. Hastings S.L.M., Myles P., McIlroy D. Aspirin and coronary artery surgery: a systematic review and meta-analysis. Br J Anaesth 2015; 115:376—385.